EAU Guidelines on Renal Cell Carcinoma: 2014 Update - Estadísticas de Google Académico

Artículos que citan EAU Guidelines on Renal Cell Carcinoma: 2014 Update

Título / Autor	Año
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial TK Choueiri, B Escudier, T Powles, NM Tannir, PN Mainwaring, BI Rini, ... The Lancet Oncology 17 (7), 917-927	2016
Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial RJ Motzer, TE Hutson, H Glen, MD Michaelson, A Molina, T Eisen, ... The lancet oncology 16 (15), 1473-1482	2015
Renal cell carcinoma JJ Hsieh, MP Purdue, S Signoretti, C Swanton, L Albiges, M Schmidinger, ... Nature reviews Disease primers 3, 17009	2017
Renal cancer U Capitanio, F Montorsi The Lancet 387 (10021), 894-906	2016
Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy L Marconi, S Dabestani, TB Lam, F Hofmann, F Stewart, J Norrie, A Bex, ... European urology 69 (4), 660-673	2016
Partial nephrectomy versus radical nephrectomy for clinical T1b and T2 renal tumors: a systematic review and meta-analysis of comparative studies MC Mir, I Derweesh, F Porpiglia, H Zargar, A Mottrie, R Autorino European urology 71 (4), 606-617	2017
Management of small renal masses: American Society of Clinical Oncology clinical practice guideline A Finelli, N Ismaila, B Bro, J Durack, S Eggener, A Evans, I Gill, D Graham, ... Journal of Clinical Oncology 35 (6), 668-680	2017
Updated EAU guidelines for clear cell renal cancer patients who fail VEGF targeted therapy T Powles, M Staehler, B Ljungberg, K Bensalah, SE Canfield, ... Eur Urol 69 (1), 4-6	2016
Non-alcoholic fatty liver disease and extra-hepatic cancers C Sanna, C Rosso, M Marietti, E Bugianesi International journal of molecular sciences 17 (5), 717	2016
Systemic therapy in metastatic renal cell carcinoma J Bedke, T Gauler, V Grünwald, A Hegele, E Herrmann, S Hinz, J Janssen, ... World journal of urology 35 (2), 179-188	2017
Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study S Dabestani, A Thorstenson, P Lindblad, U Harmenberg, B Ljungberg, ... World journal of urology 34 (8), 1081-1086	2016
Comparison of 1800 robotic and open partial nephrectomies for renal tumors B Peyronnet, T Seisen, E Oger, C Vaessen, Y Grassano, T Benoit, ... Annals of surgical oncology 23 (13), 4277-4283	2016
A systematic review and meta-analysis comparing the effectiveness and adverse effects of different systemic treatments for non-clear cell renal cell carcinoma S Fernandez-Pello, F Hofmann, R Tahbaz, L Marconi, TB Lam, L Albiges, ... European urology 71 (3), 426-436	2017
Natural history of renal angiomyolipoma (AML): most patients with large AMLs> 4 cm can be offered active surveillance as an initial management strategy JR Bhatt, PO Richard, NS Kim, A Finelli, K Manickavachagam, L Legere, ... European urology 70 (1), 85-90	2016
Updated European Association of Urology guidelines regarding adjuvant therapy for renal cell carcinoma A Bex, L Albiges, B Ljungberg, K Bensalah, S Dabestani, RH Giles, ... European urology 71 (5), 719-722	2017
Percutaneous image-guided cryoablation: current applications and results in the oncologic field RL Cazzato, J Garnon, N Ramamurthy, G Koch, G Tsoumakidou, ... Medical oncology 33 (12), 140	2016
Partial nephrectomy in clinical T1b renal tumors: multicenter comparative study of open, laparoscopic and robot-assisted approach (the RECORd Project) F Porpiglia, A Mari, R Bertolo, A Antonelli, G Bianchi, F Fidanza, C Fiori, ... Urology 89, 45-53	2016
Prediction of complications following partial nephrectomy: implications for ablative techniques candidates A Larcher, N Fossati, Z Tian, K Boehm, M Meskawi, R Valdivieso, ... European urology 69 (4), 676-682	2016
A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma JH Wei, A Haddad, KJ Wu, HW Zhao, P Kapur, ZL Zhang, LY Zhao, ... Nature communications 6, 8699	2015
Gender differences in incidence and outcomes of urothelial and kidney cancer I Lucca, T Klatte, H Fajkovic, M De Martino, SF Shariat Nature Reviews Urology 12 (10), 585	2015

1 - 20

Las fechas y los recuentos de citas son estimados y se determinan de forma automática mediante un programa informático.